Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study
- DOI
- 10.1136/annrheumdis-2012-201324
- Published
- 2012-11
- Container
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/annrheumdis-2012-201324,
title = {Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study},
author = {Juan J Gomez-Reino and Jose Ramon Maneiro and Jorge Ruiz and Rosa Roselló and Raimon Sanmarti and Ana Belen Romero},
year = {2012},
journal = {Annals of the Rheumatic Diseases},
doi = {10.1136/annrheumdis-2012-201324},
url = {https://doi.org/10.1136/annrheumdis-2012-201324}
}RIS
TY - JOUR TI - Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study AU - Juan J Gomez-Reino AU - Jose Ramon Maneiro AU - Jorge Ruiz AU - Rosa Roselló AU - Raimon Sanmarti AU - Ana Belen Romero PY - 2012 JO - Annals of the Rheumatic Diseases DO - 10.1136/annrheumdis-2012-201324 UR - https://doi.org/10.1136/annrheumdis-2012-201324 ER -
APA
Gomez-Reino, J. J., Maneiro, J. R., Ruiz, J., Roselló, R., Sanmarti, R., & Romero, A. B. (2012). Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2012-201324
Source records
- crossref · retrieved 2026-09-27T08:54:39.164Z